Eagle Asset Management Inc. trimmed its position in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 0.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 729,476 shares of the company’s stock after selling 5,710 shares during the period. Eagle […]
UBS Group Cuts 10x Genomics (NASDAQ:TXG) Price Target to $30.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
10x Genomics (NASDAQ:TXG) Releases Quarterly Earnings Results, Hits Expectations themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
10x Genomics (NASDAQ:TXG – Free Report) had its target price lowered by Canaccord Genuity Group from $65.00 to $50.00 in a report released on Monday, Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Several other equities analysts have also recently commented on TXG. Deutsche Bank Aktiengesellschaft decreased their price target […]
10x Genomics (NASDAQ:TXG – Free Report) had its price target reduced by The Goldman Sachs Group from $30.00 to $26.00 in a research report released on Wednesday, Benzinga reports. They currently have a sell rating on the stock. A number of other research firms also recently weighed in on TXG. TD Cowen downgraded shares of […]